Literature DB >> 9024070

Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer.

A H Honkoop1, H M Pinedo, J S De Jong, H M Verheul, S C Linn, K Hoekman, J Wagstaff, P J van Diest.   

Abstract

In 42 patients with locally advanced breast cancer treated with neoadjuvant chemotherapy followed by surgery and radiation therapy, the effects of chemotherapy on tumor architecture, morphometric nuclear and nucleolar characteristics, DNA ploidy, proliferation index measured by mitotic activity index, expression of differentiation antigens, and microvessel density were studied. Pretreatment biopsy specimens were available to compare with mastectomy specimens for 24 patients, and subclavicular biopsy specimens taken before chemotherapy were available for 9 patients. In the remaining patients, fine-needle aspiration was performed before chemotherapy, and morphologic and biologic features of the tumors could be studied only after chemotherapy. In 23 patients, only microscopic tumor or no tumor was left after chemotherapy, and in these patients we observed a characteristic pattern of relatively cellular fibrous tissue with lymphocytic infiltrate, ironloaded macrophages, and, when present, scattered foci of tumor cells in between. We found a reduction in mitotic activity index and in global microvessel density over all the tumors as a group. There was, however, no consistent pattern of changes in nuclear and nucleolar morphometric characteristics, DNA ploidy, and expression of differentiation antigens, and no pathologic or biologic features were predictive for response to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024070     DOI: 10.1093/ajcp/107.2.211

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  25 in total

Review 1.  Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors:  Jan Buter; Herbert M Pinedo
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

Review 2.  Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Authors:  Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-22       Impact factor: 9.236

3.  Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Authors:  Aida Kuzucan; Jeon-Hor Chen; Shadfar Bahri; Rita S Mehta; Philip M Carpenter; Peter T Fwu; Hon J Yu; David J B Hsiang; Karen T Lane; John A Butler; Stephen A Feig; Min-Ying Su
Journal:  Clin Breast Cancer       Date:  2012-04       Impact factor: 3.225

4.  Morphological effects of chemotherapy on ovarian carcinoma.

Authors:  W G McCluggage; R W Lyness; R J Atkinson; S P Dobbs; I Harley; H R McClelland; J H Price
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

5.  [Neoadjuvant chemotherapy of breast carcinomas: what post-therapeutic (preoperative) information is provided by quantitative dynamic MRI?].

Authors:  K Wasser; S K Klein; H Junkermann; H P Sinn; S Darai; W Neff; H U Kauczor; S Delorme
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

6.  Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy.

Authors:  Seok Hyung Kang; Seok-Ki Kim; Youngmee Kwon; Han-Sung Kang; Jae Hee Kang; Jungsil Ro; Eun Sook Lee
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

7.  Patterns of Regression in Breast Cancer after Primary Systemic Treatment.

Authors:  Tamás Zombori; Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2018-11-27       Impact factor: 3.201

Review 8.  Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors.

Authors:  S Avril
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

Review 9.  Prognostic value of proliferation in invasive breast cancer: a review.

Authors:  P J van Diest; E van der Wall; J P A Baak
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

Review 10.  Locally advanced breast cancer.

Authors:  W M Sikov
Journal:  Curr Treat Options Oncol       Date:  2000-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.